GalNAc-T3 as a Marker for Lung Cancer
Author Information
Author(s): Dosaka-Akita H, Kinoshita I, Yamazaki K, Izumi H, Itoh T, Katoh H, Nishimura M, Matsuo K, Yamada Y, Kohno K
Primary Institution: Hokkaido University
Hypothesis
The study investigates the expression of GalNAc-T3 in non-small cell lung cancers and its potential as a prognostic factor.
Conclusion
Low expression of GalNAc-T3 is associated with shorter survival in patients with non-small cell lung cancers.
Supporting Evidence
- Low GalNAc-T3 expression was found more frequently in smokers than nonsmokers.
- Low GalNAc-T3 expression was associated with a higher Ki-67 labelling index.
- Patients with low GalNAc-T3 expression had shorter survival times compared to those with high expression.
Takeaway
This study found that a protein called GalNAc-T3 is important for understanding lung cancer, and lower levels of it mean patients might not live as long.
Methodology
Immunohistochemistry was used to examine GalNAc-T3 expression in surgically resected non-small cell lung cancers.
Limitations
The study only included patients from a single institution and may not be generalizable.
Participant Demographics
The study included 215 patients, consisting of 142 men and 73 women.
Statistical Information
P-Value
P=0.001, P<0.0001, P=0.0002, P=0.0003, P=0.02, P=0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website